{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "IBIO INC.  DL -,001", "longName": "iBio, Inc.", "messageBoardId": "finmb_33000", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 0.91, "averageDailyVolume3Month": 1383, "averageDailyVolume10Day": 100, "fiftyTwoWeekLowChange": 0.5718, "fiftyTwoWeekLowChangePercent": 1.5963148, "fiftyTwoWeekRange": "0.3582 - 9.6375", "fiftyTwoWeekHighChange": -8.7074995, "fiftyTwoWeekHighChangePercent": -0.9035019, "fiftyTwoWeekLow": 0.3582, "fiftyTwoWeekHigh": 9.6375, "earningsTimestamp": 1676413620, "earningsTimestampStart": 1683889140, "earningsTimestampEnd": 1684324800, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -131.64, "sharesOutstanding": 12369200, "bookValue": 1.522, "fiftyDayAverage": 1.4066, "fiftyDayAverageChange": -0.4766, "fiftyDayAverageChangePercent": -0.33883122, "twoHundredDayAverage": 2.652443, "twoHundredDayAverageChange": -1.7224429, "twoHundredDayAverageChangePercent": -0.6493798, "marketCap": 11911812, "priceToBook": 0.61103815, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "regularMarketChangePercent": -2.6177986, "regularMarketPrice": 0.93, "marketState": "REGULAR", "firstTradeDateMilliseconds": 1413352800000, "priceHint": 4, "regularMarketChange": -0.024999976, "regularMarketTime": 1683892036, "regularMarketDayHigh": 0.93, "regularMarketDayRange": "0.91 - 0.93", "regularMarketDayLow": 0.91, "regularMarketVolume": 1000, "regularMarketPreviousClose": 0.955, "bid": 0.905, "ask": 0.95, "symbol": "0JV.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "8800 HSC Parkway", "city": "Bryan", "state": "TX", "zip": "77807-1107", "country": "United States", "phone": "979 446 0027", "website": "https://www.ibioinc.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates through two segments, Biopharmaceuticals and Bioprocessing. Its lead anti-fibrotic candidate is IBIO-100 for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis. The company is also developing vaccine candidates comprising IBIO-202 , which is the Nucleocapsid (N) protein for the prevention of severe acute respiratory syndrome coronavirus 2; and IBIO-400 for the treatment of classical swine fever. In addition, it is developing recombinant proteins for third parties; and offers a range of process development, manufacturing, and bio analytic services. iBio, Inc. has a license agreement with University of Pittsburgh; a non-exclusive agreement with The Texas A&M University System for designing and manufacturing of plant-made biopharmaceuticals; license agreement with the University of Natural Resources and Life Sciences, Vienna; and collaboration agreement with RubrYc. The company was incorporated in 2008 and is headquartered in Bryan, Texas.", "fullTimeEmployees": 105, "companyOfficers": [{"maxAge": 1, "name": "Dr. Martin B. Brenner D.V.M., Ph.D.", "age": 51, "title": "Interim CEO & Chief Scientific Officer", "yearBorn": 1971, "fiscalYear": 2022, "totalPay": {"raw": 578302, "fmt": "578.3k", "longFmt": "578,302"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Robert B. Kay", "age": 82, "title": "Interim Sec. & Interim Treasurer", "yearBorn": 1940, "fiscalYear": 2022, "totalPay": {"raw": 92692, "fmt": "92.69k", "longFmt": "92,692"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Felipe  Duran", "age": 42, "title": "Interim Chief Financial Officer", "yearBorn": 1980, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mike  Jenkins", "title": "VP of Operations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Stephen  Kilmer", "title": "Investor Relations Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Marc  Banjak J.D.", "title": "Gen. Counsel", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Nick  DeLong Ph.D.", "title": "VP of Corp. Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Lisa  Middlebrook", "title": "Chief HR Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 9, "boardRisk": 5, "compensationRisk": 9, "shareHolderRightsRisk": 4, "overallRisk": 7, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}